Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, remains a partially curable disease. Genetic alterations affecting components of NF-κB signaling pathways occur frequently in DLBCL. Almost all activated B cell–like (ABC) DLBCL, which is the least curable group amo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pulvino, Mary, Liang, Yue, Oleksyn, David, DeRan, Michael, Van Pelt, Elise, Shapiro, Joel, Sanz, Ignacio, Chen, Luojing, Zhao, Jiyong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429308/
https://ncbi.nlm.nih.gov/pubmed/22791293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-406074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados